ASCO 2022 Conference Coverage

 

ASCO 2022 Conference Coverage
M

ASCO 2022 CeNtuRIOn: Rucaparib With Nivo & Ipi in Relapsed Ovarian Cancer - Results of the Initial Safety Cohort

By ASCO 2022 Conference Coverage FEATURING Marcia Hall
By ASCO 2022 Conference Coverage FEATURING Marcia Hall
162 views
June 15, 2022
Comments 0
Login to view comments. Click here to Login

Featured Video

02:58
Lilly Medical Affairs

A Heterogenous Disease with Varied Clinical Outcomes: HR+/HER2- MBC

Feat. J. O’Shaughnessy

Featured Video

06:14
Lilly Medical Affairs

CDK4/6 Inhibitors as First-Line Treatment for HR+, HER2- MBC

Feat. J. O’Shaughnessy
GYN
14:34

ASCO 2022 CeNtuRIOn: Rucaparib With Nivo & Ipi in Relapsed Ovarian C…

ASCO 2022 Conference Coverage

M. Hall

162 views
07:16

ASCO 2022 Efficacy & Safety of Dostarlimab in dMMR Solid Tumors: The…

ASCO 2022 Conference Coverage

T. André

77 views
01:05

Lecture Summary - ASCO 2022 on Platinum vs. Non-Platinum Chemo for P…

ASCO 2022 Conference Coverage

A. Rumyantsev

12 views
04:38

ASCO 2022 on Platinum vs. Non-Platinum Chemo for Platinum-Resistant …

ASCO 2022 Conference Coverage

A. Rumyantsev

449 views